期刊
CURRENT DIABETES REPORTS
卷 19, 期 9, 页码 -出版社
CURRENT MEDICINE GROUP
DOI: 10.1007/s11892-019-1188-4
关键词
Diabetic macular edema; Diabetic retinopathy; Anti-VEGF; Intravitreal injection; Laser photocoagulation; Diabetes mellitus
Purpose of ReviewDiabetes mellitus is a global epidemic which is growing in prevalence, and diabetic macular edema (DME) is a leading cause of visual impairment among patients affected by this disease. Our objective is to review current and upcoming therapeutic approaches to DME.Recent FindingsOnce considered the gold standard in treatment of DME, focal/grid laser is now reserved mostly for non-center-involving DME, while anti-vascular endothelial growth factor (anti-VEGF) therapy has become the first-line treatment. However, suboptimal responders to anti-VEGF and the burden of frequent injections have stimulated the development of novel approaches. Corticosteroids can be effective in treating DME, but adverse effects such as intraocular pressure elevation and cataract formation must be considered. Emerging therapeutics and drug delivery systems in the pipeline offer exciting potential solutions to this vision-threatening disease.SummaryMultiple types of therapeutics targeting various pathways implicated in the pathogenesis of DME may help lessen the global burden of vision loss from diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据